Orthopaedics and Trauma
Volume 23, Issue 3 , Pages 180-185 , June 2009

Facioscapulohumeral muscular dystrophy assessment and treatment

References 

  1. Padberg GW. Facioscapulohumeral disease: thesis. University of Leiden; 1982;
  2. Rogers MT. Facioscapulohumeral muscular dystrophy: historical background and literature review. In:  Upadhyaya M,  Cooper DN editor. Facioscapulohumeral muscular dystrophy. New York, NY: Bios Scientific Publishers; 2004;p. 17–40
  3. Tyler FH, Stephens FE. Studies in disorders of muscle, II: clinical manifestations and inheritance of facioscapulohumeral dystrophy in a large family. Ann Intern Med. 1950;32:640–660
  4. Letournel E, Fardeau M, Lytle JO, Serrault M, Gosselin RA. Scapulothoracic arthrodesis for patients who have facioscapulohumeral muscular dystrophy. J Bone Joint Surg Am. 1990;72-A(1):78–84
  5. Diab M, Darras B, Shapiro F. Scapulothoracic fusion for facioscapulohumeral muscular dystrophy. J Bone Joint Surg Am. 2005;87-A(10):2267–2275
  6. Padberg GW. Facioscapulohumeral muscular dystrophy: a clinician's experience. In:  Upadhyaya M,  Cooper DN editor. Facioscapulohumeral muscular dystrophy. New York, NY: Bios Scientific Publishers; 2004;p. 41–54
  7. Shahrizaila N, Wills AJ. Significance of Beevors sign in FSHD and other neuromuscular diseases. J Neurol Neurosurg Psychiatr. 2005;76:869–870
  8. Olsen DB, Gideon P, Jeppesen TD, Vissing J. Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI. J Neurol. 2006;253:1437–1441
  9. Padberg GW, Lunt PW, Fardeau M. Diagnostic criteria for FSHD. Neuromuscul Disord. 1991;1:231–234
  10. Van der Kooi EL, Lindeman E, Riphagen I. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev. 2005;Issue 1. Art. No.: CD003907. doi: 10.1002/14651858.CD003907.pub2
  11. Tawil R, McDermott MP, Pandya S, et al. A pilot trial of prednisolone in facioscapulohumeral muscular dystrophy. FSH-DY Group. Neurology. 1997;48(1):46–49
  12. Kissel JT, McDermott MP, Natarajan R, et al. Pilot trial of albuterol in facioscapulo-humeral muscular dystrophy. FSH- DY Group. Neurology. 1998;50(5):1402–1406
  13. Kissel JT, McDermott MP, Mendell JR, et al. Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology. Oct 2001;57:1434–1440
  14. Rose MR, Tawil R. Drug treatment for facioscapulohumeral muscular dystrophy. Cochrane Database Syst Rev. 2004;Issue 2. Art. No.: CD002276. doi: 10.1002/14651858.CD002276.pub2
  15. Walter MC, Lochmüller H, Reilich P, et al. Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study. Neurology. May 2000;54:1848–1850
  16. Bunch WH, Siegel I. Scapulothoracic arthrodesis in facioscapulohumeral muscular dystrophy. J Bone Joint Surg Am. 1993;75-A(3):372–376
  17. Ketenjian A. Scapulocostal stabilization for scapular winging in facioscapulohumeral muscular dystrophy. J Bone Joint Surg Am. 1978;60-A(4):476–480
  18. Dickson FD. Fascial transplants in paralytic and other conditions. J Bone Joint Surg Am. 1937;19(2):405–412
  19. Copeland SA, Howard RC. Thoracoscapular fusion for facioscapulohumeral dystrophy. J Bone Joint Surg Br. 1978;60-B(4):547–551
  20. Copeland SA, Levy O, Warner GC, Dodenhoff RM. The shoulder in patients with muscular dystrophy. Clin Orthop Relat Res. 1999;368:80–91
  21. Twyman RS, Harper GD, Edgar MA. Thoracoscapular fusion in facioscapulohumeral dystrophy: clinical review of a new surgical method. J Shoulder Elbow Surg. 1996;5:201–205

PII: S1877-1327(09)00048-7

doi: 10.1016/j.mporth.2009.03.001

Orthopaedics and Trauma
Volume 23, Issue 3 , Pages 180-185 , June 2009

Article Tools

* Image Usage & Resolution